Xiaojing Shi

1.1k total citations
16 papers, 871 citations indexed

About

Xiaojing Shi is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Xiaojing Shi has authored 16 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Immunology. Recurrent topics in Xiaojing Shi's work include Extracellular vesicles in disease (6 papers), RNA Interference and Gene Delivery (6 papers) and MicroRNA in disease regulation (6 papers). Xiaojing Shi is often cited by papers focused on Extracellular vesicles in disease (6 papers), RNA Interference and Gene Delivery (6 papers) and MicroRNA in disease regulation (6 papers). Xiaojing Shi collaborates with scholars based in United States and China. Xiaojing Shi's co-authors include Qinqin Cheng, Yong Zhang, Heinz‐Josef Lenz, Goar Smbatyan, Yiying Zhang, Nancy Chen, Yi‐Hao Yu, Li Liu, Tianling Hou and Julie E. Lang and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaojing Shi

15 papers receiving 865 citations

Peers

Xiaojing Shi
Matthias Schewe Netherlands
Ru‐Ting Huang United States
Zhe Cheng China
Andrea Matter United States
Maaike Meerlo Netherlands
Aleksey Yevtodiyenko United States
Matthias Schewe Netherlands
Xiaojing Shi
Citations per year, relative to Xiaojing Shi Xiaojing Shi (= 1×) peers Matthias Schewe

Countries citing papers authored by Xiaojing Shi

Since Specialization
Citations

This map shows the geographic impact of Xiaojing Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Shi more than expected).

Fields of papers citing papers by Xiaojing Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Shi. The network helps show where Xiaojing Shi may publish in the future.

Co-authorship network of co-authors of Xiaojing Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojing Shi. A scholar is included among the top collaborators of Xiaojing Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojing Shi. Xiaojing Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chen, Yuan, et al.. (2025). Salinomycin inhibits porcine epidemic diarrhea virus infection by targeting Wnt/β-catenin pathway. International Immunopharmacology. 155. 114652–114652.
2.
Zhang, Lei, Zeyu Zhang, Xiaojing Shi, et al.. (2025). Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemia. Molecular Therapy. 33(3). 1091–1104. 3 indexed citations
3.
Shi, Xiaojing, et al.. (2024). Development of environmental DNA metabarcoding primers for marine mollusks and comparison with published primers. SHILAP Revista de lepidopterología. 24(1). 73–73. 1 indexed citations
4.
Shi, Xiaojing. (2024). Application of Genetic Algorithm to the Traditional Layout and Spatial Optimization Design of Suzhou Gardens. Applied Mathematics and Nonlinear Sciences. 9(1). 1 indexed citations
5.
Zhao, Feng, et al.. (2024). Fronts affect fish community structure in the Yangtze River estuary and its adjacent area. Journal of Sea Research. 199. 102507–102507. 2 indexed citations
6.
Cheng, Qinqin, et al.. (2021). Expanding the toolbox of exosome-based modulators of cell functions. Biomaterials. 277. 121129–121129. 28 indexed citations
7.
Wu, Xiaoping, Lin Cheng, Changsheng Song, et al.. (2021). Constructing carbon-coated Fe3O4 hierarchical microstructures with a porous structure and their excellent Cr(VI) ion removal properties. Journal of Materials Science Materials in Electronics. 32(15). 20844–20855. 3 indexed citations
8.
Shi, Xiaojing & Yong Zhang. (2020). A humanized antibody inhibitor for cathepsin L. Protein Science. 29(9). 1924–1930. 6 indexed citations
9.
Shi, Xiaojing, Xiaonan Zhang, Jingwen Chen, et al.. (2020). A poly-ADP-ribose polymer-based antibody-drug conjugate. Chemical Science. 11(34). 9303–9308. 17 indexed citations
10.
Cheng, Qinqin, Xiaojing Shi, & Yong Zhang. (2019). Reprogramming Exosomes for Immunotherapy. Methods in molecular biology. 2097. 197–209. 21 indexed citations
11.
Shi, Xiaojing, Qinqin Cheng, & Yong Zhang. (2019). Reprogramming extracellular vesicles with engineered proteins. Methods. 177. 95–102. 19 indexed citations
12.
Shi, Xiaojing, Qinqin Cheng, Tianling Hou, et al.. (2019). Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy. Molecular Therapy. 28(2). 536–547. 194 indexed citations
13.
Cheng, Qinqin, et al.. (2018). Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity. Journal of the American Chemical Society. 140(48). 16413–16417. 238 indexed citations
15.
Qiu, Yanyan, Xiaojing Shi, Ke Xu, et al.. (2016). microRNA‐497 inhibits invasion and metastasis of colorectal cancer cells by targeting vascular endothelial growth factor‐A. Cell Proliferation. 49(1). 69–78. 38 indexed citations
16.
Liu, Li, et al.. (2007). Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. Journal of Clinical Investigation. 117(6). 1679–1689. 280 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026